EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Brain‐Derived Neurotrophic Factor (BDNF) as a Potential Biomarker in Brain Glioma: A Systematic Review and Meta‐Analysis

Fatemeh Hasani iD, Mahdi Masrour, Sina Khamaki, Kimia Jazi, Erfan Ghoodjani, Antonio L Teixeira

Brain and Behavior · 2025-01 · 15 (1)

DOI: 10.1002/brb3.70266 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Brain and Behavior, online erschienen am 09.01.2025. Verfasst von Fatemeh Hasani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Brain Neoplasms, Brain-Derived Neurotrophic Factor, Glioma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This systematic review and meta‐analysis evaluates peripheral and CNS BDNF levels in glioma patients.

Methods

Following PRISMA guidelines, we systematically searched databases for studies measuring BDNF in glioma patients and controls. After screening and data extraction, we conducted quality assessment, meta‐analysis, and meta‐regression.

Results

Eight studies were included. Meta‐analysis showed significantly reduced plasma BDNF levels in glioma patients versus controls (SMD: −1.0026; 95% CI: [−1.5284, −0.4769], p = 0.0002). High‐grade gliomas had lower plasma BDNF ( p = 0.0288). Tissue BDNF levels were higher in glioma patients (SMD: 1.9513; 95% CI: [0.7365, 3.1661], p = 0.0016) and correlated with tumor grade ( p = 0.0122). Plasma BDNF levels negatively correlated with patient age ( p = 0.0244) and positively with female percentage ( p = 0.0007).

Conclusion

BDNF is a promising biomarker in glioma, showing significant changes in plasma and tissue levels correlating with tumor grade, patient age, and gender.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorBrain NeoplasmsBrain-Derived Neurotrophic FactorGliomaHumans

Stichwörter der Autor:innen

BDNFbiomarkerbrain neoplasmsbrain‐derived neurotrophic factorglioblastomaglioma

Substanzen

BDNF protein, humanBiomarkers, TumorBrain-Derived Neurotrophic Factor

Autor:innen und Institutionen

  • Gastroenterology and Hepatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Student Research Committee, Faculty of Medicine, Medical University of Qom, Qom, Iran.
  • School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Biggs Institute, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

ORCID-Profile: Fatemeh Hasani

Zitieren

APA

Hasani, F., Masrour, M., Khamaki, S., Jazi, K., Ghoodjani, E., & Teixeira, A. L. (2025). Brain‐Derived Neurotrophic Factor (BDNF) as a Potential Biomarker in Brain Glioma: A Systematic Review and Meta‐Analysis. Brain and Behavior, 15(1). https://doi.org/10.1002/brb3.70266

Vancouver

Hasani F, Masrour M, Khamaki S, Jazi K, Ghoodjani E, Teixeira AL. Brain‐Derived Neurotrophic Factor (BDNF) as a Potential Biomarker in Brain Glioma: A Systematic Review and Meta‐Analysis. Brain and Behavior. 2025;15(1). doi:10.1002/brb3.70266

BibTeX
@article{Hasani2025,
  author = {Hasani, Fatemeh and Masrour, Mahdi and Khamaki, Sina and Jazi, Kimia and Ghoodjani, Erfan and Teixeira, Antonio L},
  title = {Brain‐Derived Neurotrophic Factor (BDNF) as a Potential Biomarker in Brain Glioma: A Systematic Review and Meta‐Analysis},
  journal = {Brain and Behavior},
  year = {2025},
  volume = {15},
  number = {1},
  doi = {10.1002/brb3.70266}
}
Kostenlos starten →